Norway Royal Salmon ASA (NRS): Update on regulatory approvals related to the merger between Norway Royal Salmon ASA and SalMar ASA

Report this content

Reference is made to the proposed merger between SalMar ASA ("SalMar") and Norway Royal Salmon ASA ("NRS") (the "Merger") pursuant to the merger plan dated 30 May 2022 (the "Merger Plan"). The Merger Plan was approved by the respective general meetings of NRS and SalMar held on 30 June 2022.

The Merger is conditional upon, among other things, that all conditions for the completion of SalMar's recommended voluntary offer to acquire all outstanding shares in NTS ASA ("NTS") (the "Offer"), as set out in the offer document dated 17 March 2022 (the "Offer Document"), have been satisfied, waived, or that the Offer has been completed.

The Norwegian Competition Authority has today approved SalMar's contemplated acquisition of all outstanding shares in NTS in accordance with the Offer, and thus also the Merger. However, the Merger and the Offer remain subject to receipt of further approvals from competition authorities, including the European Commission, and such other conditions as set out in the Merger Plan and Offer Document.

.

For more information, please contact:

Paal Espen Johnsen, Chairman of the Board of Directors: +47 484 02 000

Charles Høstlund, CEO: +47 994 18 449

.

About Norway Royal Salmon:

The Norway Royal Salmon (NRS) group owns 36 085 tonnes MAB for salmon farming located in Troms and Finnmark, and 21 800 tonnes MAB for salmon farming and 5 300 MAB for trout farming on Iceland through the company Arctic Fish. In addition, the group has minority interest in two associated Norwegian fish farming companies which together own nine fish farming licenses. NRS is an attractively positioned fish farming group, which offers salmon to the market through its own sales organisation. For further details, please visit www.norwayroyalsalmon.com.

This information is subject to the disclose requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Subscribe